News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,185 Results
Type
Article (39115)
Company Profile (282)
Press Release (647788)
Section
Business (203898)
Career Advice (1993)
Deals (35369)
Drug Delivery (88)
Drug Development (80843)
Employer Resources (168)
FDA (16096)
Job Trends (14807)
News (344628)
Policy (32451)
Tag
Academia (2530)
Alliances (49146)
Alzheimer's disease (1250)
Approvals (16031)
Artificial intelligence (143)
Bankruptcy (352)
Best Places to Work (11564)
Biotechnology (201)
Breast cancer (173)
Cancer (1298)
Cardiovascular disease (106)
Career advice (1661)
Cell therapy (267)
Clinical research (64576)
Collaboration (440)
Compensation (244)
COVID-19 (2538)
C-suite (106)
Data (1351)
Diabetes (162)
Diagnostics (6165)
Earnings (84873)
Employer resources (146)
Events (109902)
Executive appointments (357)
FDA (16715)
Funding (402)
Gene therapy (191)
GLP-1 (590)
Government (4330)
Healthcare (18683)
Infectious disease (2625)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16321)
Job creations (3625)
Job search strategy (1417)
Layoffs (415)
Legal (7860)
Lung cancer (185)
Manufacturing (194)
Medical device (13205)
Medtech (13210)
Mergers & acquisitions (19169)
Metabolic disorders (429)
Neuroscience (1560)
NextGen Class of 2024 (6500)
Non-profit (4466)
Northern California (1628)
Obesity (250)
Opinion (180)
Patents (113)
People (56380)
Phase I (20077)
Phase II (28438)
Phase III (21207)
Pipeline (498)
Postmarket research (2560)
Preclinical (8534)
Radiopharmaceuticals (236)
Rare diseases (247)
Real estate (5891)
Regulatory (21615)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1414)
Startups (3562)
United States (14615)
Vaccines (558)
Weight loss (175)
Date
Today (158)
Last 7 days (660)
Last 30 days (2909)
Last 365 days (35414)
2024 (34261)
2023 (40076)
2022 (51175)
2021 (55713)
2020 (54089)
2019 (46541)
2018 (35020)
2017 (32109)
2016 (31480)
2015 (37556)
2014 (31325)
2013 (26353)
2012 (28572)
2011 (29264)
2010 (27329)
Location
Africa (713)
Arizona (194)
Asia (37216)
Australia (6074)
California (3652)
Canada (1389)
China (286)
Colorado (166)
Connecticut (168)
Europe (79733)
Florida (506)
Georgia (128)
Illinois (367)
Indiana (215)
Kansas (96)
Maryland (612)
Massachusetts (2846)
Michigan (167)
Minnesota (284)
New Jersey (1055)
New York (1042)
North Carolina (728)
Northern California (1628)
Ohio (144)
Pennsylvania (896)
South America (1091)
Southern California (1414)
Texas (524)
Utah (105)
Washington State (384)
687,185 Results for "velos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Velo3D Announces the Commencement of OTCQX Trading
September 11, 2024
·
3 min read
Drug Development
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease
HanAll Biopharma Co., Ltd. (KRX: 009420. KS) announced the initiation of a Phase III VELOS-4 trial evaluating the efficacy and safety of tanfanercept, a novel, topical anti-inflammatory treatment in participants with moderate to severe dry eye disease (DED).
May 3, 2024
·
7 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Drug Development
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease
HanAll Biopharma Co., Ltd. announced results from the Phase III VELOS-3 trial evaluating the safety and efficacy of tanfanercept, a novel, topical anti-inflammatory treatment being studied for the treatment of dry eye disease (DED) in subjects diagnosed with moderate to severe DED.
May 19, 2023
·
7 min read
Lymphoma
Merck Touts 100% Complete Response Rate for Anti-ROR1 ADC as First-Line Lymphoma Treatment
Analysts called the data “very competitive” but raised questions about safety. Merck gained ownership of the ADC when it acquired VelosBio in November 2020 for $2.75 billion.
December 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock
December 11, 2024
·
6 min read
Press Releases
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
December 10, 2024
·
10 min read
Press Releases
WW International, Inc. Announces CFO Transition
November 27, 2024
·
4 min read
1 of 68,719
Next
